Legend Capital
Legend Capital Healthcare
With a team of 13 professionals dedicated to the healthcare funds; Legend Capital began investing in the healthcare sector in 2007 and have made more than 170 investments across the healthcare ecosystem, deploying in excess of US$1.8 bn. LC have rich portfolios ranging from ADC, Bispecifics and small molecules in the area of oncology, metabolism, immunology and neurology.
Also look for cooperation opportunities for one of portfolios, which focuses on non-opioid analgesics. First product NDA approval by both FDA and NMPA for moderate-to-severe pain. Second product at Ph3 for postoperative pain and potential first at least 72h long-acting ropivacaine injection. An additional highly selective next-generation Nav1.8 inhibitor. Contact me for details.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}